(TRA016) The Immunological Mechanism of Plasma EBV DNA Clearance during Radiotherapy in Patients with Nasopharyngeal Carcinoma-a pilot study
Chair:
Prof. Brigette Ma
Eligibility:
Adult patients with histologically confirmed non-keratinizing nasopharyngeal carcinoma previously untreated and are planned for curative treatment.
Objectives:
To investigate changes in T-cell mediated immune response in patients undergoingRT alone or concurrent chemoradiotherapy (CRT) for nasopharyngeal carcinoma(NPC).